Ticker Details
Lyell Immunopharma, Inc.
IPO Date:	June 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$556.38M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.14%
Avg Daily Range (30 D):	$0.76 | 3.39%
Avg Daily Range (90 D):	$0.96 | 3.70%

Institutional Daily Volume
Avg Daily Volume:	.62M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.08M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	41

Institutional Trades
Total Institutional Trades:	348
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.41M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.3M
Avg Closing Trade (30 D):	$1.16M
Avg Closing Trade (90 D):	$2.26M
Avg Closing Volume:	29.37K

News

Mar 9, 2026 @ 12:00 PM Lyell Immunopharma Announces Closing of Additional... Source: Na

Dec 9, 2025 @ 1:00 PM Century Therapeutics Appoints Accomplished Biotech... Source: Century Therapeutics

Dec 7, 2025 @ 9:30 PM Lyell Immunopharma Presents New Clinical Data from... Source: Lyell Immunopharma

Nov 3, 2025 @ 2:00 PM Lyell Announces Two Oral Presentations from the Ph... Source: Lyell Immunopharma, Inc.

Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-16.06	$-7.68	$-16.06
Diluted EPS	$-16.06	$-7.68	$-16.06
Revenue	$.04M	$.01M	$.04M
Gross Profit
Net Income / Loss	$-274.45M	$-140.72M	$-274.45M
Operating Income / Loss	$-269.4M	$-127.64M	$-269.4M
Cost of Revenue
Net Cash Flow	$-45.52M	$-63.39M	$-45.52M
PE Ratio

Splits
Jun 02, 2025	1:20